Anti-NCAN/ CSPG3 functional antibody

Anti-NCAN/ CSPG3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NCAN/NCAN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1122-Ab-1/ GM-Tg-hg-SE1122-Ab-2Anti-Human NCAN monoclonal antibodyHuman
GM-Tg-rg-SE1122-Ab-1/ GM-Tg-rg-SE1122-Ab-2Anti-Rat NCAN monoclonal antibodyRat
GM-Tg-mg-SE1122-Ab-1/ GM-Tg-mg-SE1122-Ab-2Anti-Mouse NCAN monoclonal antibodyMouse
GM-Tg-cynog-SE1122-Ab-1/ GM-Tg-cynog-SE1122-Ab-2Anti-Cynomolgus/ Rhesus macaque NCAN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1122-Ab-1/ GM-Tg-felg-SE1122-Ab-2Anti-Feline NCAN monoclonal antibodyFeline
GM-Tg-cang-SE1122-Ab-1/ GM-Tg-cang-SE1122-Ab-2Anti-Canine NCAN monoclonal antibodyCanine
GM-Tg-bovg-SE1122-Ab-1/ GM-Tg-bovg-SE1122-Ab-2Anti-Bovine NCAN monoclonal antibodyBovine
GM-Tg-equg-SE1122-Ab-1/ GM-Tg-equg-SE1122-Ab-2Anti-Equine NCAN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1122-Ab-1/ GM-Tg-hg-SE1122-Ab-2; GM-Tg-rg-SE1122-Ab-1/ GM-Tg-rg-SE1122-Ab-2;
GM-Tg-mg-SE1122-Ab-1/ GM-Tg-mg-SE1122-Ab-2; GM-Tg-cynog-SE1122-Ab-1/ GM-Tg-cynog-SE1122-Ab-2;
GM-Tg-felg-SE1122-Ab-1/ GM-Tg-felg-SE1122-Ab-2; GM-Tg-cang-SE1122-Ab-1/ GM-Tg-cang-SE1122-Ab-2;
GM-Tg-bovg-SE1122-Ab-1/ GM-Tg-bovg-SE1122-Ab-2; GM-Tg-equg-SE1122-Ab-1/ GM-Tg-equg-SE1122-Ab-2
Products NameAnti-NCAN monoclonal antibody
Formatmab
Target NameNCAN
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NCAN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1122-Ag-1Recombinant multi-species NCAN/ CSPG3 protein


    Target information

    Target IDGM-SE1122
    Target NameNCAN
    Gene ID1463,13004,58982,720340,484808,101090998,523701,100147158
    Gene Symbol and SynonymsC230035B04,CSPG3,Cspg3-rs,NCAN,Tgfbit
    Uniprot AccessionO14594,P55067
    Uniprot Entry NameNCAN_HUMAN,NCAN_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130287
    Target ClassificationN/A

    The target: NCAN, gene name: NCAN, also named as CSPG3. Neurocan is a chondroitin sulfate proteoglycan thought to be involved in the modulation of cell adhesion and migration.[supplied by OMIM, Jul 2002].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.